LAPORTE KATHLEEN sold BOLT
December 12, 2025 · Form 4 insider transaction
LAPORTE KATHLEEN sold 1,392 shares of Bolt Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,392
Price
N/A
Total value
N/A
InsiderLAPORTE KATHLEEN
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person agreed to cancellation of an option granted on December 29, 2020, in exchange for a new option having a lower exercise price.; The option is fully vested and exercisable.